Use of insulin-sensitizing agents in patients with polycystic ovary syndrome

To review the subject of polycystic ovary syndrome and the therapeutic use of insulin-sensitizing agents in patients with this endocrinopathy. We present background information on this disorder and summarize the pertinent published literature. Polycystic ovary syndrome affects approximately 7.5% of...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Endocrine practice 2001-07, Vol.7 (4), p.279-286
Hauptverfasser:	Bloomgarden, Z T, Futterweit, W, Poretsky, L
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgens - blood Anovulation Chromans - therapeutic use Female Follicle Stimulating Hormone - blood Humans Hyperandrogenism Hypoglycemic Agents - therapeutic use Inositol - therapeutic use Luteinizing Hormone - blood Metformin - therapeutic use Polycystic Ovary Syndrome - diagnosis Polycystic Ovary Syndrome - drug therapy Thiazoles - therapeutic use Thiazolidinediones Troglitazone
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!